This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Eli Lilly and Company. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Thomas M Eckrich: Innovator in Pharmaceutical Chemistry
Introduction
Thomas M Eckrich is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibiotic compounds. With a total of 3 patents, his work has had a meaningful impact on drug formulation and development.
Latest Patents
Eckrich's latest patents include innovative formulations such as DMF solvates of a .beta.-lactam antibiotic. His work on the crystalline bis(DMF), dihydrate mono(DMF), and mono(DMF) forms of 7.beta.-[2'-(R)-2'-phenyl-2'-aminoacetamido]-3-chloro-3-(1-carbadethiaceph em)-4-carboxylic acid (LY163892) highlights the importance of these compounds as useful intermediates to the monohydrate form of LY163892. Additionally, he has developed a method for resolving cis - Cis .alpha..alpha./.beta..beta.-3-amino-[2-(2-furyl)eth-1-yl]-1-methoxycarbony lmethyl-azetidin-2-one via optically active malic acid.
Career Highlights
Throughout his career, Thomas M Eckrich has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company. His expertise in drug development has positioned him as a valuable asset in the field.
Collaborations
Eckrich has collaborated with notable professionals such as John Brennan and Brett D Boyer. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Thomas M Eckrich's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to influence the development of important antibiotic compounds.